Unlocking Stranded Innovation for Children: How CobiCure Is Reimagining Access to Life-Changing Therapies
Aligned with ASGCT's vision for advancing "stranded innovation", CobiCure is rescuing promising but commercially abandoned therapies for children with rare diseases.
Read more
CobiCure Therapeutics Launches to Develop New Medicines for Pediatric Cancers and Rare Diseases
August 7, 2025 | New nonprofit endeavor will focus on accelerating promising therapies that would otherwise be overlooked by traditional biotech funders
Read moreFrankel Foundation Ignites $10 Million Accelerator at CobiCure for Pediatric Clinical Development
July 30, 2025 | Landmark investment establishes dedicated accelerator to fast-track life-saving innovations to accelerate clinical development for pediatric medical devices and therapies for childhood cancer and rare diseases
Read more
